Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Published in: Journal of Neuro-Oncology 2/2017

01-09-2017 | Retraction Note

Retraction Note to: Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients

Authors: Jian-tong Jiao, Jun Sun, Jian-fen Ma, Min-chao Dai, Jin Huang, Chen Jiang, Cheng Wang, Chao Cheng, Jun-fei Shao

Published in: Journal of Neuro-Oncology | Issue 2/2017

Login to get access

Excerpt

The Editor and Publisher have retracted this article because the authors are unable to provide sufficient documentation of the study, including details of all the patients treated that would substantiate the facts in this paper. The authors disagree with this retraction. …
Metadata
Title
Retraction Note to: Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients
Authors
Jian-tong Jiao
Jun Sun
Jian-fen Ma
Min-chao Dai
Jin Huang
Chen Jiang
Cheng Wang
Chao Cheng
Jun-fei Shao
Publication date
01-09-2017
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2017
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2592-8

Other articles of this Issue 2/2017

Journal of Neuro-Oncology 2/2017 Go to the issue

Topic Review

Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomas

Clinical Study

Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma

Clinical Study

Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1

Letter to the Editor

Intracranial granulocytic sarcoma as the first presentation of chronic myeloid leukemia in chronic phase

Clinical Study

Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling

Clinical Study

Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab